83 FR 15583 - National Institute of General Medical Sciences; Notice of Meeting

DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health

Federal Register Volume 83, Issue 70 (April 11, 2018)

Page Range		15583-15583
FR Document		2018-07396

Federal Register, Volume 83 Issue 70 (Wednesday, April 11, 2018)

[Federal Register Volume 83, Number 70 (Wednesday, April 11, 2018)]
[Notices]
[Page 15583]
From the Federal Register Online  [www.thefederalregister.org]
[FR Doc No: 2018-07396]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Institute of General Medical Sciences; Notice of Meeting

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended, notice is hereby given of a meeting of the National Advisory 
General Medical Sciences Council.
    The meeting will be open to the public as indicated below, with a 
short public comment period at the end. Attendance is limited by the 
space available. Individuals who plan to attend and need special 
assistance, such as sign language interpretation or other reasonable 
accommodations, should notify the Contact Person listed below in 
advance of the meeting. The open session will also be videocast and can 
be accessed from the NIH Videocasting and Podcasting website (http://videocast.nih.gov).
    The meeting will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended. The grant applications and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable material, and personal information concerning individuals 
associated with the grant applications, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Comittee: National Advisory General Medical Sciences 
Council.
    Date: May 24-25, 2018.
    Closed: May 24, 2018, 9:00 a.m. to 5:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health, Natcher Building, 
Conference Rooms E1 & E2, 45 Center Drive, Bethesda, MD 20892.
    Open: May 25, 2018, 8:30 a.m. to 12:00 p.m.
    Agenda: For the discussion of program policies and issues; 
opening remarks; report of the Director, NIGMS; and other business 
of the Council.
    Place: National Institutes of Health, Natcher Building, 
Conference Rooms E1 & E2, 45 Center Drive, Bethesda, MD 20892.
    Contact Person: Ann A. Hagan, Ph.D., Associate Director for 
Extramural Activities, NIGMS, NIH, DHHS, 45 Center Drive, Room 
2AN24H, MSC 6200, Bethesda, MD 20892-6200, (301) 594-4499, 
[email protected].

    Any interested person may file written comments with the 
committee by forwarding the statement to the Contact Person listed 
on this notice. The statement should include the name, address, 
telephone number and when applicable, the business or professional 
affiliation of the interested person.
    In the interest of security, NIH has instituted stringent 
procedures for entrance onto the NIH campus. All visitor vehicles, 
including taxicabs, hotel, and airport shuttles will be inspected 
before being allowed on campus. Visitors will be asked to show one 
form of identification (for example, a government-issued photo ID, 
driver's license, or passport) and to state the purpose of their 
visit.
    Information is also available on the Institute's/Center's home 
page: http://www.nigms.nih.gov/About/Council, where an agenda and 
any additional information for the meeting will be posted when 
available.

(Catalogue of Federal Domestic Assistance Program Nos. 93.859, 
Biomedical Research and Research Training, National Institutes of 
Health, HHS)

    Dated: April 5, 2018.
Melanie J. Pantoja,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2018-07396 Filed 4-10-18; 8:45 am]
 BILLING CODE 4140-01-P

Federal Register / Vol. 83, No. 70 / Wednesday, April 11, 2018 / Notices 15583

safety. These sections describe essential provisions set forth in sections DEPARTMENT OF HEALTH AND
considerations intended to provide 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., HUMAN SERVICES
high-level guidance on the as amended. The grant applications and
implementation of these approaches in the discussions could disclose National Institutes of Health
pediatric drug development and have confidential trade secrets or commercial
been revised based on comments property such as patentable material, National Cancer Institute; Notice of
received from global stakeholders. and personal information concerning Meeting
This guidance is being issued individuals associated with the grant Pursuant to section 10(a) of the
consistent with FDA’s good guidance applications, the disclosure of which Federal Advisory Committee Act, as
practices regulation (21 CFR 10.115). would constitute a clearly unwarranted amended, notice is hereby given of a
The guidance represents the current invasion of personal privacy. meeting of the Frederick National
thinking of FDA on ‘‘E11(R1) Laboratory Advisory Committee to the
Name of Comittee: National Advisory
Addendum: Clinical Investigation of General Medical Sciences Council. National Cancer Institute.
Medicinal Products in the Pediatric Date: May 24–25, 2018. The meeting will be open to the
Population.’’ It does not establish any Closed: May 24, 2018, 9:00 a.m. to 5:00 public, with attendance limited to space
rights for any person and is not binding p.m. available. Individuals who plan to
on FDA or the public. You can use an Agenda: To review and evaluate grant attend and need special assistance, such
alternative approach if it satisfies the applications. as sign language interpretation or other
requirements of the applicable statutes Place: National Institutes of Health, reasonable accommodations, should
and regulations. This guidance is not Natcher Building, Conference Rooms E1 & notify the Contact Person listed below
subject to Executive Order 12866. E2, 45 Center Drive, Bethesda, MD 20892. in advance of the meeting. The meeting
II. Electronic Access Open: May 25, 2018, 8:30 a.m. to 12:00 will also be videocast and can be
p.m. accessed from the NIH Videocasting and
Persons with access to the internet Agenda: For the discussion of program Podcasting website (http://
may obtain the guidance at https:// policies and issues; opening remarks; report videocast.nih.gov/).
www.regulations.gov, https:// of the Director, NIGMS; and other business
www.fda.gov/Drugs/ Name of Committee: Frederick National
of the Council. Laboratory Advisory Committee to the
GuidanceComplianceRegulatory Place: National Institutes of Health, National Cancer Institute.
Information/Guidances/default.htm, or Natcher Building, Conference Rooms E1 & Date: May 8, 2018.
https://www.fda.gov/BiologicsBlood E2, 45 Center Drive, Bethesda, MD 20892. Time: 9:00 a.m. to 5:00 p.m.
Vaccines/GuidanceCompliance Contact Person: Ann A. Hagan, Ph.D., Agenda: Ongoing and new activities at the
RegulatoryInformation/Guidances/ Associate Director for Extramural Activities, Frederick National Laboratory for Cancer
default.htm. NIGMS, NIH, DHHS, 45 Center Drive, Room Research.
2AN24H, MSC 6200, Bethesda, MD 20892– Place: National Cancer Institute Shady
Dated: April 4, 2018. Grove, 9609 Medical Center Drive,
Leslie Kux, 6200, (301) 594–4499, hagana@
Conference Room TE406, Rockville, MD
nigms.nih.gov. 20850.
Associate Commissioner for Policy.
Any interested person may file written Contact Person: Caron A. Lyman, Ph.D.,
[FR Doc. 2018–07375 Filed 4–10–18; 8:45 am]
comments with the committee by forwarding Executive Secretary, National Cancer
BILLING CODE 4164–01–P Institute, National Institutes of Health, 9609
the statement to the Contact Person listed on
this notice. The statement should include the Medical Center Drive, Room 7W–126,
name, address, telephone number and when Bethesda, MD 20892, 240–276–6348,
DEPARTMENT OF HEALTH AND lymanc@mail.nih.gov.
applicable, the business or professional
HUMAN SERVICES affiliation of the interested person. Any interested person may file written
In the interest of security, NIH has comments with the committee by forwarding
National Institutes of Health the statement to the Contact Person listed on
instituted stringent procedures for entrance
this notice. The statement should include the
National Institute of General Medical onto the NIH campus. All visitor vehicles, name, address, telephone number and when
Sciences; Notice of Meeting including taxicabs, hotel, and airport shuttles applicable, the business or professional
will be inspected before being allowed on affiliation of the interested person.
Pursuant to section 10(d) of the campus. Visitors will be asked to show one In the interest of security, NCI Shady Grove
Federal Advisory Committee Act, as form of identification (for example, a has instituted stringent procedures for
amended, notice is hereby given of a government-issued photo ID, driver’s license, entrance into the NCI Shady Grove building.
meeting of the National Advisory or passport) and to state the purpose of their Visitors will be asked to show one form of
General Medical Sciences Council. visit. identification (for example, a government-
The meeting will be open to the Information is also available on the issued photo ID, driver’s license, or passport)
and to state the purpose of their visit.
public as indicated below, with a short Institute’s/Center’s home page: http://
Information is also available on the
public comment period at the end. www.nigms.nih.gov/About/Council, where an Institute’s/Center’s home page: http://
Attendance is limited by the space agenda and any additional information for deainfo.nci.nih.gov/advisory/fac/fac.htm,
available. Individuals who plan to the meeting will be posted when available. where an agenda and any additional
attend and need special assistance, such (Catalogue of Federal Domestic Assistance information for the meeting will be posted
as sign language interpretation or other Program Nos. 93.859, Biomedical Research when available.
reasonable accommodations, should and Research Training, National Institutes of (Catalogue of Federal Domestic Assistance
notify the Contact Person listed below Health, HHS) Program Nos. 93.392, Cancer Construction;
amozie on DSK30RV082PROD with NOTICES

in advance of the meeting. The open 93.393, Cancer Cause and Prevention
Dated: April 5, 2018. Research; 93.394, Cancer Detection and
session will also be videocast and can
Melanie J. Pantoja, Diagnosis Research; 93.395, Cancer
be accessed from the NIH Videocasting Treatment Research; 93.396, Cancer Biology
and Podcasting website (http:// Program Analyst, Office of Federal Advisory
Committee Policy. Research; 93.397, Cancer Centers Support;
videocast.nih.gov). 93.398, Cancer Research Manpower; 93.399,
The meeting will be closed to the [FR Doc. 2018–07396 Filed 4–10–18; 8:45 am] Cancer Control, National Institutes of Health,
public in accordance with the BILLING CODE 4140–01–P HHS)

VerDate Sep<11>2014 17:17 Apr 10, 2018 Jkt 244001 PO 00000 Frm 00034 Fmt 4703 Sfmt 4703 E:\FR\FM\11APN1.SGM 11APN1

Document Created: 2018-04-10 23:59:42
Document Modified: 2018-04-10 23:59:42

Category		Regulatory Information
Collection		Federal Register
sudoc Class		AE 2.7: GS 4.107: AE 2.106:
Publisher		Office of the Federal Register, National Archives and Records Administration
Section		Notices
Dates		May 24-25, 2018.
FR Citation		83 FR 15583

83 FR 15583 - National Institute of General Medical Sciences; Notice of Meeting

DEPARTMENT OF HEALTH AND HUMAN SERVICESNational Institutes of Health

Federal Register Volume 83, Issue 70 (April 11, 2018)

DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health